Speaker

Dr Mathew Adams
Departmental Officer
Biological Science Section
Scientific Evaluation Branch
Therapeutic Goods Administration
Australia

Ms Judith Arcidiacono 
International Regulatory Expert and
Standards Development Liaison
Office of Cellular Tissue and Gene Therapy
U.S. Food and Drug Administration

Dr Fouad Atouf 
Vice President
Science—Global Biologics
The United States Pharmacopeial Convention

Dr Sudipto Bari 
Senior Research Fellow,
National Cancer Centre
Singapore

Dr Lucas Chan 
Co-founder CSO
CellVec

Dr Marieta Chan 
Laboratory Director & Consultant Scientist
Health Sciences Authority
Singapore

Dr Patrick Celis 
Scientific Administrator (CAT Secretariat)
European Medicines Agency

Dr Azizah Abd Ghani
Head of Biologic Section
National Pharmaceutical Regulatory Agency
Malaysia

Dr Francesca Lorraine Lim 
Senior Consultant Hematologist
Singapore General Hospital
Assistant Medical Director
Cell Therapy Facility
Health Science Authority
Singapore
.tmb-thumbnail.jpg?Culture=en&sfvrsn=27b45315_1)
Dr Shinichi Noda 
Deputy Review Director
Office of Cellular and Tissue-based
Pharmaceuticals and Medical Devices Agency
Japan

Dr Bernice Oh
Consultant
Division of Paediatric Haematology and Oncology
National University Hospital

Dr Lee Lee Ong
Regulatory Consultant
Advanced Therapy Products Branch
Health Products Regulation Group
Health Sciences Authority
Singapore

Ms Phua Chwee Ping 
Head of Patient Safety
Regional PVO Manager
AMAC
Novartis
Dr Martina Schüssler-Lenz
Chair
EMA Committee for Advanced Therapies
Paul-Ehrlich-Institut (PEI)
Federal Institute for Vaccines and Biomedicines
Germany

Dr Kellathur Srinivasan 
Director
Advanced Therapy Products Branch
Health Sciences Authority
Singapore

Dr Lawrence Starke 
Global Unit Head
Regulatory Affairs (CMC)
Cell & Gene Therapy
Novartis

Dr Tan Lip Kun
Senior Consultant and Medical Director
Tissue Engineering & Cell Therapy Laboratory
National University Hospital
Singapore

Dr Elaine Tang
Senior Regulatory Specialist (GMP)
Audit & Licensing Division, HPRG
Health Sciences Authority
Singapore

Ms Katherine Tsokas 
Vice President Regulatory,
Quality Risk Management & Drug Safety
Janssen, Canada

Dr Steve Winitsky
Vice President - Technical
Paraxel Consulting

Dr Xiaofeng Wu
Regulatory Consultant
Innovation Office and Clinical Trials Branch
Health Sciences Authority
Singapore